Published By : Prameya News Bureau | October 13, 2020 IST
Share
Washington, Oct 13: US pharmaceutical giant Johnson & Johnson announced that it has temporarily paused its Covid-19 vaccine trial after a participant became unwell."We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," Xinhua news agency quoted the company as saying in a statement on Monday.The patient's condition was being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board as well as internal clinical and safety physicians, it added."Based on our strong commitment to safety, all clinical studies conducted by the Janssen Pharmaceutical Companies of Johnson & Johnson have pre-specified guidelines. These ensure our studies may be paused if an unexpected serious adverse event (SAE) that might be related to a vaccine or study drug is reported, so there can be a careful review of all of the medical information before deciding whether to restart the study," the company statement further said."We must respect this participant's privacy. We're also learning more about this participant's illness, and it's important to have all the facts before we share additional information."Serious adverse events are not uncommon in clinical trials, and the number of serious adverse events can reasonably be expected to increase in trials involving large numbers of participants. Further, as many trials are placebo-controlled, it is not always immediately apparent whether a participant received a study treatment or a placebo," it addedThe vaccine is being developed by the company's Janssen arm, CNN said in a news report.The company however, did not mention what the illness was.Trials are stopped when they pop up while doctors check to see if the illness can be linked to the vaccine or is a coincidence.Johnson's Phase 3 trial started in September and it id one of six coronavirus vaccines being tested in the US, and one of four in the most advanced, Phase 3 stage.This is the second Phase 3 coronavirus vaccine trial to be paused in the US.AstraZeneca's vaccine trial was paused last month because of a neurological complication in a volunteer in the UK.While the trial resumed in the UK and in other countries, it remains halted in the US while it is being probed by the Food and Drug Administration investigates. (IANS)
News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
AIIMS Bhubaneswar introduces specialized unit for heat stroke patients
Conquering Anxiety: Insights from Psychiatry Prof. Dr. Surjeet Sahoo
SUM Ultimate Medicare (SUMUM) receives JCI prime certification
Know strategies to overcome social anxiety
SUM Hospital conducts Odisha’s first haploidentical hematopoitic stem transplantation
The silent storm: How stress wreaks havoc on your body
More than 5 grams of artificial sweetener saccharin a day can be fatal: Doctors
Low vision clinic inaugurated at AIIMS Bhubaneswar
Loneliness can cause an extreme desire for sugary foods: Study
Experts urge parents to wean children off social media
HK, Singapore food regulators red flag ‘cancer-causing’ ingredient in certain MDH, Everest spices
SUP’ORT training program for physiotherapists held at SUMUM
Patient awareness and interaction programme marks World Liver Day at AIIMS Bhubaneswar
Rising cases of pediatric liver issues linked to junk food epidemic
Vital organ, vital importance: Why maintaining liver health matters
World Liver Day 2024: These factors contribute to liver damage
Nestle baby food sugar study causes concern in India, Nestle India's shares fall
World Voice Day observed at SUM Phulnakhara Campus
Cadaveric kidney transplant performed at SCB Hospital
Closure of regn counter sparks tension at Bhubaneswar AIIMS